IRadimed Corp (IRMD) stock
IRMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3060% above fair value
$85.35+0.12 (+0.14%)
Close on Nov 13, 2026Market cap $1.09BP/E 45.6Yield –
IRadimed profit margin
Profit margin (net margin) is net income as a percentage of revenue.
IRadimed's profit margin for the twelve months ending Sep 30, 2026 was 26.8%. For fiscal 2025 it was 26.8%, against 26.3% the year before. The highest annual figure on record is 26.8% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 26.8% | +0.6 |
| FY2024 | Dec 31, 2024 | 26.3% | +0.0 |
| FY2023 | Dec 31, 2023 | 26.2% | +2.2 |
| FY2022 | Dec 31, 2022 | 24.1% | +1.8 |
| FY2021 | Dec 31, 2021 | 22.3% | +18.0 |
| FY2020 | Dec 31, 2020 | 4.3% | −20.7 |
| FY2019 | Dec 31, 2019 | 25.0% | +4.3 |
| FY2018 | Dec 31, 2018 | 20.7% | +18.5 |
| FY2017 | Dec 31, 2017 | 2.2% | −20.0 |
| FY2016 | Dec 31, 2016 | 22.2% | −1.6 |
| FY2015 | Dec 31, 2015 | 23.8% | +10.7 |
| FY2014 | Dec 31, 2014 | 13.1% | −4.0 |
| FY2013 | Dec 31, 2013 | 17.1% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 26.9% | +0.6 |
| Q2 FY2026 | Jun 30, 2026 | 25.5% | −2.8 |
| Q1 FY2026 | Mar 31, 2026 | 26.5% | +2.4 |
| Q4 FY2025 | Dec 31, 2025 | 28.4% | +1.8 |
| Q3 FY2025 | Sep 30, 2025 | 26.3% | −1.3 |
| Q2 FY2025 | Jun 30, 2025 | 28.3% | +1.0 |
| Q1 FY2025 | Mar 31, 2025 | 24.0% | +0.5 |
| Q4 FY2024 | Dec 31, 2024 | 26.5% | +0.5 |
| Q3 FY2024 | Sep 30, 2024 | 27.6% | −3.1 |
| Q2 FY2024 | Jun 30, 2024 | 27.3% | +1.4 |
| Q1 FY2024 | Mar 31, 2024 | 23.5% | +1.5 |
| Q4 FY2023 | Dec 31, 2023 | 26.0% | +1.3 |
| Q3 FY2023 | Sep 30, 2023 | 30.7% | +5.1 |
| Q2 FY2023 | Jun 30, 2023 | 25.9% | +0.4 |
| Q1 FY2023 | Mar 31, 2023 | 22.0% | +1.8 |
| Q4 FY2022 | Dec 31, 2022 | 24.7% | −8.1 |
| Q3 FY2022 | Sep 30, 2022 | 25.6% | +1.9 |
| Q2 FY2022 | Jun 30, 2022 | 25.5% | +10.5 |
| Q1 FY2022 | Mar 31, 2022 | 20.2% | +5.2 |
| Q4 FY2021 | Dec 31, 2021 | 32.8% | +25.3 |
| Q3 FY2021 | Sep 30, 2021 | 23.6% | +9.7 |
| Q2 FY2021 | Jun 30, 2021 | 15.0% | +46.1 |
| Q1 FY2021 | Mar 31, 2021 | 15.0% | −5.4 |
| Q4 FY2020 | Dec 31, 2020 | 7.5% | −22.3 |
| Q3 FY2020 | Sep 30, 2020 | 14.0% | −10.7 |
| Q2 FY2020 | Jun 30, 2020 | -31.1% | −53.7 |
| Q1 FY2020 | Mar 31, 2020 | 20.4% | −1.5 |
| Q4 FY2019 | Dec 31, 2019 | 29.8% | +9.3 |
| Q3 FY2019 | Sep 30, 2019 | 24.6% | −6.9 |
| Q2 FY2019 | Jun 30, 2019 | 22.6% | +4.3 |
| Q1 FY2019 | Mar 31, 2019 | 21.9% | +10.0 |
| Q4 FY2018 | Dec 31, 2018 | 20.5% | +17.7 |
| Q3 FY2018 | Sep 30, 2018 | 31.5% | +28.1 |
| Q2 FY2018 | Jun 30, 2018 | 18.4% | +11.9 |
| Q1 FY2018 | Mar 31, 2018 | 11.8% | +16.4 |
| Q4 FY2017 | Dec 31, 2017 | 2.7% | −16.3 |
| Q3 FY2017 | Sep 30, 2017 | 3.4% | – |
| Q2 FY2017 | Jun 30, 2017 | 6.5% | – |
| Q1 FY2017 | Mar 31, 2017 | -4.5% | – |
| Q4 FY2016 | Dec 31, 2016 | 19.0% | – |
See a number that looks wrong?